NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Practice this question and more.

Mycophenolate mofetil increases the risk of:

Infection and lymphoma
Anaphylaxis
Hypokalemia
Gingival hyperplasia

The correct answer is: Infection and lymphoma

Mycophenolate mofetil is an immunosuppressant medication commonly used in transplantation to prevent rejection of transplanted organs. One of its known side effects is the increased risk of infection and lymphoma. This is because mycophenolate mofetil works by suppressing the immune system, which can lead to a higher susceptibility to infections and an increased risk of lymphoma development. Therefore, it is important for healthcare providers to monitor patients taking mycophenolate mofetil closely for signs of infections and lymphoma. Options B, C, and D are incorrect: - Anaphylaxis is a severe, potentially life-threatening allergic reaction that is not typically associated with mycophenolate mofetil use. - Hypokalemia refers to low potassium levels in the blood and is not a known side effect of mycophenolate mofetil. - Gingival hyperplasia is a side effect commonly associated with calcium channel blockers such as nifedipine, not with mycophenolate mofetil.